Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ViroCell Biologics specializes in the design, optimization, and GMP manufacture of lentiviral and retroviral vectors. The company enables academic and corporate clients to accelerate translational cell and gene therapies from lab to clinic by providing high-quality viral vectors. It does not have its own therapeutic pipeline but supports numerous external programs through its CDMO services. The company has developed ~200 complex viral vectors over more than two decades of collective team experience.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ViroCell Biologics.